GRANULES INDIA
|
GRANULES INDIA Last 5 Year Financial Ratios History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 24.01 | 20.68 | 16.72 | 21.34 | 16.64 |
| CEPS(Rs) | 35.96 | 29.98 | 25.28 | 28.97 | 23.04 |
| DPS(Rs) | 1.75 | 1.50 | 1.50 | 1.50 | 1.50 |
| Book NAV/Share(Rs) | 190.45 | 152.63 | 132.33 | 116.38 | 103.62 |
| Tax Rate(%) | 24.20 | 24.03 | 25.93 | 24.82 | 26.03 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 11.83 | 12.69 | 13.07 | 20.24 | 19.17 |
| EBIT Margin(%) | 8.97 | 10.25 | 9.97 | 16.47 | 15.44 |
| Pre Tax Margin(%) | 7.83 | 8.86 | 8.35 | 15.23 | 14.82 |
| PAT Margin (%) | 5.94 | 6.73 | 6.19 | 11.45 | 10.96 |
| Cash Profit Margin (%) | 8.89 | 9.76 | 9.35 | 15.54 | 15.18 |
| Performance Ratios | |||||
| ROA(%) | 8.60 | 8.60 | 7.80 | 10.97 | 10.04 |
| ROE(%) | 14.13 | 14.52 | 13.46 | 19.18 | 17.49 |
| ROCE(%) | 15.74 | 16.16 | 15.66 | 19.63 | 17.37 |
| Asset Turnover(x) | 1.45 | 1.28 | 1.26 | 0.96 | 0.92 |
| Sales/Fixed Asset(x) | 2.26 | 2.06 | 2.07 | 1.66 | 1.63 |
| Working Capital/Sales(x) | 5.98 | 6.70 | 7.96 | 5.93 | 4.36 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.44 | 0.49 | 0.48 | 0.60 | 0.61 |
| Receivable days | 33.72 | 47.23 | 53.89 | 75.78 | 81.94 |
| Inventory Days | 54.92 | 64.75 | 68.26 | 86.07 | 85.35 |
| Payable days | 136.11 | 156.05 | 138.29 | 112.38 | 114.29 |
| Valuation Parameters | |||||
| PER(x) | 25.87 | 23.56 | 25.71 | 13.62 | 18.40 |
| PCE(x) | 17.27 | 16.25 | 17.01 | 10.04 | 13.29 |
| Price/Book(x) | 3.26 | 3.19 | 3.25 | 2.50 | 2.96 |
| Yield(%) | 0.28 | 0.31 | 0.35 | 0.52 | 0.49 |
| EV/Net Sales(x) | 2.94 | 2.79 | 2.50 | 1.73 | 2.20 |
| EV/Core EBITDA(x) | 13.09 | 13.05 | 13.08 | 8.39 | 11.19 |
| EV/EBIT(x) | 17.55 | 16.38 | 17.24 | 10.47 | 14.25 |
| EV/CE(x) | 2.46 | 2.50 | 2.53 | 2.00 | 2.25 |
| M Cap / Sales | 2.87 | 2.64 | 2.31 | 1.56 | 2.02 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 19.73 | -0.55 | -0.12 | 19.84 | 16.29 |
| Core EBITDA Growth(%) | 25.81 | 11.36 | -7.25 | 25.38 | -16.13 |
| EBIT Growth(%) | 17.81 | 16.90 | -12.12 | 27.85 | -20.45 |
| PAT Growth(%) | 18.64 | 23.74 | -21.54 | 25.16 | -24.88 |
| EPS Growth(%) | 16.13 | 23.65 | -21.65 | 28.24 | -24.98 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.28 | 0.35 | 0.38 | 0.38 | 0.43 |
| Current Ratio(x) | 1.80 | 1.56 | 1.40 | 1.42 | 1.53 |
| Quick Ratio(x) | 1.00 | 0.88 | 0.77 | 0.79 | 0.93 |
| Interest Cover(x) | 7.86 | 7.39 | 6.17 | 13.29 | 25.04 |
| Total Debt/Mcap(x) | 0.09 | 0.11 | 0.12 | 0.15 | 0.14 |
Compare Financial Ratios of peers of GRANULES INDIA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GRANULES INDIA | ₹20,657.8 Cr | -4.8% | 8.1% | 69.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹465,711.0 Cr | -0.8% | 3.5% | 14.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹192,376.0 Cr | -1% | 7.3% | 7.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,655.0 Cr | -0.9% | 10.1% | 44.6% | Stock Analytics | |
| CIPLA | ₹113,979.0 Cr | -2.1% | -1.8% | -6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,204.7 Cr | -5.8% | -13.2% | -7.7% | Stock Analytics | |
GRANULES INDIA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GRANULES INDIA | -4.8% |
8.1% |
69.6% |
| SENSEX | -2.7% |
-0.2% |
-8% |
You may also like the below Video Courses
